Karyopharm Therapeutics Inc. - Common Stock (KPTI)

8.5350
+0.0350 (0.41%)
NASDAQ· Last Trade: Jun 9th, 1:35 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026